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Abstract
CD9P-1 is a cell surface protein with immunoglobulin domains and an unknown function that specifically associates with
tetraspanins CD9 and CD81. Overexpression of CD9P-1 in HEK-293 cells induces dramatic changes in cell spreading and
migration on various matrices. Experiments using time-lapse videomicroscopy revealed that CD9P-1 expression has led to
higher cell motility on collagen I but lower motility on fibronectin through a b1-integrins dependent mechanism. On
collagen I, the increase in cell motility induced by CD9P-1 expression was found to involve integrin a2b1 and CD9P-1 was
observed to associate with this collagen receptor. The generation of CD9P-1 mutants demonstrated that the
transmembrane and the cytoplasmic domains are necessary for inducing effects on cell motility. On the other hand,
expression of tetraspanins CD9 or CD81 was shown to reverse the effects of CD9P-1 on cell motility on collagen I or
fibronectin with a concomitant association with CD9P-1. Thus, the ratio of expression levels between CD9P-1 and its
tetraspanin partners can regulate cell motility.
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Introduction
Tetraspanins are integral membrane proteins characterized by
significant sequence identity and specific structural features [1–3].
They are highly expressed on many cell types and have been
involved in a large variety of physiological and pathological
processes such as immune response, reproduction and develop-
ment, infectious and genetic diseases as well as metastasis [1–9].
For example, it has been demonstrated using knock-out mice that
the tetraspanin CD9 plays an essential role in reproduction
because CD9 deficient mice exhibited severely reduced female
fertility because of impaired gamete fusion [10]. Another
tetraspanin has been shown to be involved in the immune
response as CD81 knock-out mice exhibit an impaired immune
response [1,11]. On the other hand, this tetraspanin has been
identified as a receptor involved in hepatitis C virus infection [12].
Similarly, CD81 expression is necessary for Plasmodium falciparum
entry into hepatocytes [4]. The tetraspanin CD151 has been
described to be essential for the correct assembly of human
basement membranes in kidney and skin [6,13,14].
At the molecular level, tetraspanins associate with each other as
well as with numerous other membrane proteins in particular
microdomains on the plasma membrane [9,15]. Several tetra-
spanins such as CD9, CD63, CD81 and CD151 have been shown
to associate with one or a few specific molecular partners, forming
small primary complexes [15,16]. CD9 associates directly with the
membrane precursor proHB-EGF (heparin-binding epidermal
growth factor) [17,18] and EpCAM (epithelial cell adhesion
molecule) [19], while CD81 associates with the signaling molecule
CD19 [20] and integrin a4b1 [16]. In addition, both tetraspanins
CD9 and CD81 have been shown to specifically associate with two
molecules with immunoglobulin (Ig) domains, CD9P-1 and EWI-2
[2,21–25]. Likewise, the tetraspanin CD63 associates specifically
with H,K-ATPase [26] whereas CD151 associates directly with
the integrins a3b1, a6b1, a7b1 and a6b4 [2,16,27].
Tetraspanins may regulate the expression and trafficking of
their molecular partners. CD81, which was initially described as a
component of the CD21/CD19/Leu13 complex involved in B-
lymphoid cell activation [1], has been demonstrated to be
necessary for the expression of its partner CD19 at cell surface
of B-lymphocytes [1,28]. In the absence of CD81, a major
reduction of CD19 expression level was observed at cell surface
that was correlated with CD19 retention in the endoplasmic
reticulum [28,29]. The tetraspanin CD63 by associating with
H,K-ATPase beta subunit allows for its internalization into
stomach parietal cells [26]. In contrast, downregulation of
CD151 expression significantly slows the internalization rate of
integrin a3b1 in cells plated on its main ligand, laminin-5 [30].
Tetraspanins have also been reported to regulate the activity
and function of their associated molecules. For example, CD9
expression has been described to increase the binding of
diphtheria toxin (DT) on its receptor proHB-EGF, which is
associated with CD9 [17]. The increase of DT-sensitivity of the
cells was correlated with a higher number of functional binding
sites on the receptor, most likely induced by conformational
changes [17]. In addition, CD9 expression regulates the juxtacrine
activity of membrane-bound HB-EGF factor [31]. It has been
demonstrated that CD81 facilitates adhesion of leukocytes on
VCAM-1 by increasing the avidity of integrin a4b1 toward its
substrate VCAM-1 [32]. CD151 stabilizes the active conformation
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activity of integrin a3b1 [33] or a6b1 [34], CD151 markedly
influences cell spreading and cellular morphogenesis [35,36].
Hence, it has been suggested that primary complexes constitute
functional units.
In this report, we focus on the functional relevance of primary
complexes formed by tetraspanins CD9 or CD81 with CD9P-1.
Given that some tetraspanins play a major role in metastasis [8], in
particular CD9 which has been reported as a metastasis
suppressor, we have addressed the function of CD9P-1 on cell
migration that is an important process in metastasis. We show that
CD9P-1 overexpression induces dramatic changes in cell migra-
tion. We further demonstrate that CD9 and CD81 regulate
CD9P1-induced effects on cell motility.
Materials and Methods
Cell culture and matrices
The cell line HEK-293 (human embryonic kidney) was obtained
from the ATCC. Cell lines stably expressing wild type or mutant
CD9P-1 have been described elsewhere [37,38]. HEK-293 was
transfected with pCDNA3 vector (Invitrogen) to establish the cell
line HEK-293 mock. All cell lines were cultured in DMEM
supplemented with 10% FCS, 2 mM glutamine and antibiotics (all
from Invitrogen, Cergy-Pontoise, France). Cells were maintained
in a 37uC humidified incubator in the presence of 5% CO2. Cells
were culture on plastic or on matrices after coating with 15 mg/ml
poly-L-ornithine (Sigma), 50 mg/ml collagen I (BD Bioscience),
100 mg/ml matrigel (BD Bioscience), 50 mg/ml laminin-5 or
50 mg/ml fibronectin (Roche).
Plasmids, transfection and RNA silencing
Encoding cDNA sequence for CD9P-1, CD9, CD81, CD82,
CD151 or chimeric molecules CD9682, CD9P1-HLA-TM-Cyt,
CD9P1-HLA-TM, CD9P1-HLA-Cyt were subcloned in the
pCDNA3 vector (Invitrogen) as reported elsewhere [38]. For
transfection, 5610
6 cells were electroporated in 0.4 ml RPMI at
room temperature with 10 mg of cDNA using a gene pulser
apparatus (Biorad, Ivry, France). The conditions were 300 V and
500 mF for all cell lines.
For RNA silencing, 1–3610
5 cells in DMEM medium were
transfected with synthetic siRNA oligonucleotides using Interferin
(Ozyme) according to the manufacturer’s protocol. Cell culture
plates (6, 12 or 24 well) were coated with rat tail collagen I (BD
Biosciences). Plates were rinsed in PBS, and 1 ml of the siRNA
(10 mM) oligonucleotide mix was added to 96 ml DMEM without
Table 1. Expression of tetraspanins and integrins on HEK-293
and HEK/CD9P-1 cells.
Cell line CD9 CD81 CD82 CD151 Int. a1I n t .a2I n t .b1
HEK-293 +++ +++ 2 +++ + + ++
HEK/CD9P-1 +++ +++ 2 ++ + + ++
HEK/CD9P1-HLA-TM-Cyt +++ +++ 2 +++ + + ++
HEK/CD9P1-HLA-TM +++ +++ 2 +++ + + ++
HEK/CD9P1-HLA-Cyt +++ +++ 2 +++ + + ++
HEK/CD9P-1 Tr CD9 ++++
HEK/CD9P-1 Tr CD81 ++++
HEK/CD9P-1 Tr CD82 ++++
HEK/CD9P-1 Tr CD151 ++++
HEK/CD9P-1 Tr CD9682 +++
Fluorescence intensity: 2,10; +: 10–50; ++: 50–100; +++: 100–300; ++++.300.
Tr: transfection.
doi:10.1371/journal.pone.0011219.t001
Figure 1. CD9P-1 overexpression affects HEK-293 cell spread-
ing. HEK-293 or HEK/CD9P-1 cells were enzymatically dissociated and
plated on various matrices for 24h. (A) Laminin-5. (B) Matrigel. (C) Collagen
I. (D) Fibronectin. Cells were photographed with phase contrast (2006).
Close up sections are shown with higher magnification (C and D).
doi:10.1371/journal.pone.0011219.g001
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temperature in each well for 20 min to allow formation of
transfection complexes. Cells detached by trypsin-EDTA were
layered at the appropriate concentration in 400 ml DMEM
medium with serum (the final concentration of siRNA was
20 nM). The following siRNA were synthesized by Eurogentec
(Angers, France), si-CD9P-1: AUGUUCAACCCCCAGCA-
CAdTdT, si-control: ACCUCCUCCAGCUCGCUUAdTdT.
Antibodies
The monoclonal antibodies used in this study were TS9 (CD9),
TS9b (CD9), TS81 (CD81), TS82 (CD82), TS151 (CD151)
[19,24,39], 1F11 (CD9P-1) [24], 12A12 (CD55) [40]. Antibodies
directed against integrins were: b1-integrin, 4B4 (Beckman
Coulter), b1-vjf; a1-integrin, FB12 (Millipore); a2-integrin, Gi9
(Sigma), H-293 (Santa Cruz Biotechnology, Santa Cruz, CA).
Immunofluorescence
For flow cytometry analysis of cell surface molecules, cells were
detached using a non-enzymatic solution (Invitrogen), washed and
stained with saturating concentrations of primary mAb (10 mg/
ml). After washing three times with media, cells were incubated
with 10 mg/ml FITC-labeled goat anti-mouse antibody (Beckman
Coulter). After washing, cells were fixed with 1% formaldehyde in
PBS. All incubations were performed for 30 min at 4uC. The
analysis of cell surface staining was performed using a FACSca-
libur flow cytometer (Becton-Dickinson, San Jose, CA).
For in situ labeling, cells were cultured in labtek chambers. Cells
were fixed in acetone at 220uC for 20 min followed by three washes
with PBS 0.2% BSA, 10% SVF. Immunostaining was performed in
the chambers with primary antibodies at 10 mg/ml for 45 min. After
three washes, the appropriate fluorochrome coupled secondary
antibodies (anti-IgG1 coupled to Alexa 568 and anti-IgG2 coupled to
Alexa 488 (Invitrogen)) were incubated at the same concentration.
For staining of chromatin, an additional incubation was performed
with 300 nM DAPI (Invitrogen) for 5 min. Fluorescent labeling was
observed with an optical microscope equipped for epifluorescence
(Leica, Heerbrugg, Swiss). Images were acquired using MetaVue
(Molecular Devices, Toronto, Canada).
Immunoprecipitation and Western blot
Cells were lysed directly in the flask in the lysis buffer (10 mM
Tris pH 7.4, 150 mM NaCl, 0.02% NaN3, 1 mM CaCl2 and
1 mM MgCl2) containing 1% of appropriate detergent (Brij97 or
Figure 2. CD9P-1 overexpression affects HEK-293 cell migration. HEK-293 or HEK/CD9P-1 cells were plated on various matrices. The same
field of cells was monitored over a period of 24h while being maintained in a microscope stage incubator. Time-lapse videomicroscopy was
performed at a rate of 1 frame per 15 min. Independent experiments were performed: laminin-5 (n=3), matrigel (n=3), collagen I (n=20), fibronectin
(n=11); standard errors are shown.
doi:10.1371/journal.pone.0011219.g002
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30 min at 4uC, insoluble material was removed by centrifugation
at 12,000 g and the cell lysate was precleared for 2h by addition of
1/1000 volume heat inactivated goat serum and 20 ml protein G
sepharose beads (Amersham Bioscience). Proteins were then
immunoprecipitated by adding 2 mg of specific antibody and
10ml protein G sepharose beads to 200–400 ml lysate. After a 2h
incubation at 4uC under constant agitation, the beads were
washed five times in lysis buffer containing 1% of appropriate
detergent. The immunoprecipitates were separated by 5–15%
SDS-polyacrylamide gel electrophoresis under reducing or non-
reducing conditions and transferred to a PVDF or nitrocellulose
membrane (Amersham Bioscience). Western blotting on immu-
noprecipitates was performed using specific mAbs. With PVDF
membranes, the revelation was realized by enhanced chemilumi-
nescence (NEN, Boston, MA) after incubation with a streptavidin-
biotinylated horseradish peroxidase complex (Amersham Biosci-
ence) when the primary antibody was coupled with biotin;
otherwise a secondary goat anti-mouse antibody coupled to
horseradish peroxidase (Amersham Bioscience) was used. Proteins
on nitrocellulose membranes were revealed with Alexa Fluor 680-
labelled streptavidin (Invitrogen) or an Alexa Fluor 680-labelled
secondary goat anti-mouse antibody (Invitrogen) using the
Odyssey Infrared Imaging System (LI-COR Biosciences).
Quantitation of stained gels
For quantitative analysis, after SDS-PAGE separation, gels were
stained with colloidal Coomassieb l u e( B i o R a d )o rt h eK r y p t o n
Infrared Protein Stain (Pierce), according to the manufacturer’s
protocol. Gels were scanned at 700 nm using the Odyssey Infrared
Imaging System (LI-COR Biosciences), which allows for quantitation.
Cell migration assay using time-lapse videomicroscopy or
Boyden chambers
Analysis of 2D cell motility was performed using phase contrast
on an inverted microscope (Axiovert 200; Zeiss,Oberkochen,
Germany) equipped with an environmental chamber with 5%
CO2 at 37uC. The microscope was driven by the Metamorph
software (Roper Scientific), and images were recorded with a
Coolsnap HQ camera (Roper Scientific). Stacks of phase contrast
images were collected every 15 min for 24 h at 2006magnifica-
tion. Cell migration was quantified using the manual tracking
plugin of ImageJ [41]. Raw data were transferred to Microsoft
Excel for calculations. For each position at least 10 cells were
analyzed. Experiments were repeated 2 to 10 times to verify the
robustness of the results and the stability of the measurements. For
plasmid transfection or silencing experiments, motility measures
were performed respectively 24 h and 48 h after treatments.
Cell migration was also investigated using the Boyden chamber
assay. In brief, transwell inserts (Corning) with 5 mm pores were
coated with collagen I (50 mg/ml) or fibronectin (50 mg/ml). Cells
were detached using trypsin and 2610
4 cells were plated in the
upper chamber and allowed to invade for 18 hours. Noninvasive
cells were removed from the upper chamber with a cotton swab,
and migrating cells adhering to the underside of the filter were
fixed, stained with May Grumwald and Giemsa and enumerated
using an optical microscope. A minimum of 5 random fields per
filter were counted. All of the experiments were performed
independently in duplicate or triplicate.
Statistical analysis of variance (ANOVA) was performed using
Microsoft Excel. Results were considered significant when
p,0.05.
Results
CD9P-1 overexpression induces dramatic changes in cell
aggregation and spreading
To study CD9P-1 function, HEK-293 cells stably expressing
CD9P-1 (HEK/CD9P-1) were established and used as a model.
The expression levels of tetraspanins (CD9, CD81, CD82 and
CD151) and b1-integrins (a1, a2 and b1) were checked at cell
surface using flow cytometry. HEK-293 and HEK/CD9P-1
Figure 3. HEK-293 and HEK/CD9P-1 cell migration on collagen I. (A) HEK-293 or HEK/CD9P-1 cells were plated on collagen I. The same field of
cells was monitored over a period of 24h while being maintained in a microscope stage incubator. Time-lapse videomicroscopy was performed at a
rate of 1 frame per 15 min. Three independent experiments were performed; standard errors are shown. (B) Time-lapse videomicroscopy was
performed following CD9P-1 silencing by siRNA. Distances are given over a period of 20h. The results correspond to three independent experiments;
standard errors are shown. (C) Cell migration through collagen I was measured using Boyden chambers. Migrating cells adhering to the underside of
the filter were enumerated in a minimum of 5 random fields. The results correspond to five independent experiments performed in duplicate or
triplicate; standard errors are shown.
doi:10.1371/journal.pone.0011219.g003
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transfected cell population as well as two selected clones were used
for functional assays. Cells were plated on various matrices such as
collagen I, laminin-5, fibronectin or matrigel. HEK-293 and
HEK/CD9P-1 exhibited different morphology in cell cultured.
Indeed, HEK-293 cells formed aggregates after 24h enzymatic
dissociation. In contrast, reaggregation and spreading of HEK/
CD9P-1 cells were impaired on collagen I and fibronectin (Fig. 1).
These observations demonstrate that CD9P-1 expression can
dramatically change cell aggregation and spreading.
CD9P-1 overexpression induces dramatic changes in cell
migration
The motility of HEK-293 and HEK/CD9P-1 cells was investigated
and compared using time-lapse videomicroscopy. Cells were again
plated on various matrices such as collagen I, laminin-5, fibronectin or
Figure 4. Functional and physical link between CD9P-1 and a2b1 integrin. (A) Time-lapse videomicroscopy experiments were performed
with HEK-293 or HEK/CD9P-1 cells. Monoclonal antibodies directed against integrins a1 (FB12) or a2 (Gi9) were added in the media (10 mg/ml).
Independent experiments were performed (n=6); standard errors are shown; (*) p,0.01. (B) Cells were lysed using the mild detergent Brij58 and
immunoprecipitation experiments were performed with mAbs directed against CD9P-1 (1F11), a2-integrin (Gi9), b1-integrin (9D6) and CD55. After
electrophoresis and transfer to a membrane, Western blotting was performed using a2-integrin antibody H-293.
doi:10.1371/journal.pone.0011219.g004
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15 min. Hence, tracking individual cells allowed quantifying cell
motility. HEK-293 and HEK/CD9P-1 cells exhibited very low
motility on laminin-5. On matrigel, both cell lines showed similar
motility with a mean rate of 16 mm/h. On fibronectin, HEK-293
exhibited a high motility with a mean rate of 30 mm/h. However,
expression of CD9P-1 significantly decreased cell motility on
fibronectin to 14 mm/h. Finally, HEK/CD9P-1 cells were observed
to be highly motile on collagen I (37 mm/h) compared with HEK-293
cells (16 mm/h) (Fig. 2). This functional effect of CD9P-1 expression on
cell migration was observed with the whole stably transfected cell
population (pool) as well as two selected clones (Fig. 3A). To confirm
that CD9P-1 plays a role in cell motility, silencing experiments were
performed to knock down CD9P-1 expression. HEK/CD9P-1 cells
were transfected by CD9P-1 oligonucleotide for RNA interference.
The expression level was checked by flow cytometry 48h after
treatment showing 80% knock down at cell surface. It should be noted
that CD9P-1 silencing was stable for more than 72h. Thus, cells were
plated on collagen I for 48h after treatment and videomicroscopy
experiments were performed. CD9P-1 silencing dramatically decreases
cell motility on collagen I of HEK/CD9P-1 as well as HEK-293
(Fig. 3B). Migration of HEK-293 and HEK/CD9P-1 cells was also
investigated using Boyden chamber assay. An increase of invading
HEK/CD9P-1 cells was observed compared to HEK-293 cells when
inserts were coated with collagen I (Fig. 3C).
Altogether, these observations demonstrate that CD9P-1
expression can dramatically change cell migration.
CD9P1-induced cell motility on collagen I involves a2b1
integrin
The mechanisms underlying CD9P-1 expression’s effect on cell
migration wereinvestigated. The involvement of b1-integrins which
play a role in cell adhesion and migration as receptors of
extracellular matrices [42] was addressed. We focused on the
mechanism underlying cell migration on collagen I because CD9P-
1 expression induced an increase of cell motility on this matrix. The
use of the blocking antibody 4B4 showed that cell motility of HEK-
293 and HEK/CD9P-1 cells is dependent on b1-integrins because
cells were no longer migrating on collagen I when the antibody was
added to the culture media (data not shown).
The major cellular receptors of the matrix collagen I are the
integrins a1b1 and a2b1 [42]. Thus, possible involvement of these
integrins was investigated using blocking antibodies. Cell motility
of HEK-293 cells on collagen I was not influenced when adding
a1-integrin or a2-integrin blocking antibodies separately. Howev-
er, HEK-293 cell motility was significantly inhibited when both
antibodies were added to the culture media. These results suggest
that cell migration of HEK-293 cells on collagen I can be mostly
driven by either integrins a1b1o ra2b1 because when one is
inhibited the other may compensate. In contrast, the treatment of
HEK/CD9P-1 cells with the a2-integrin blocking antibody
decreased cell motility to a similar level as that observed with
HEK-293 cells whereas a1-integrin blocking antibody had no
effect. When both antibodies a1- and a2-integrins were added in
HEK/CD9P-1 cell culture media, cell motility was inhibited as
observed with HEK-293 cells (Fig. 4A). These observations suggest
that CD9P-1 expression increases cell motility on collagen I
through the possible involvement of a2b1 integrin.
A link between CD9P-1 and a2b1 integrin was investigated.
HEK-293 and HEK/CD9P-1 cells were lysed using the mild
detergent Brij58. Immunoprecipitation experiments were per-
formed with mAbs CD9P-1, a2-integrin, b1-integrin and CD55 as
a control. Under these conditions, a2-integrin was shown to be
associated with CD9P-1 only in HEK/CD9P-1 cells (Fig. 4B).
Figure 5. Structure-function relationship of CD9P-1 on cell motility. Wild type CD9P-1 exhibiting six Ig domains, transmembrane domain
(TM) and a cytoplasmic domain (Cyt) is represented. CD9P-1 chimeric forms were generated by replacing the transmembrane and/or the cytoplasmic
domain by the corresponding domains of HLA class I protein (shaded boxes). Time-lapse videomicroscopy experiments were performed on collagen I
or fibronectin with cell lines expressing wild type or chimeric forms of CD9P-1. Three independent experiments were performed; standard errors are
shown.
doi:10.1371/journal.pone.0011219.g005
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required for inducing effects on cell migration
The regions of the CD9P-1 protein involved in cell migration
were investigated. Chimeric proteins were generated in which the
transmembrane and/or the cytoplasmic domains of CD9P-1 were
replaced by corresponding domains from HLA class I. Cell lines
stably expressing the chimeric proteins were established using
HEK-293 cells [38]. Cells were plated on collagen I or fibronectin.
The motility of these cell lines was investigated and compared to
HEK-293 and HEK/CD9P-1 using time-lapse videomicroscopy.
None of the chimeric proteins were able to promote cell migration
on collagen I or to induce its inhibition on fibronectin (Fig. 5).
Figure 6. Effects of tetraspanins on CD9P1-induced cell motility on collagen I. (A) HEK/CD9P-1 cells were transfected with tetraspanins
CD9, CD81, CD82, CD151 or CD9682. Then, cells were plated on collagen I. Time-lapse videomicroscopy was performed at a rate of 1 frame per
15 min for 24h. The results correspond to six independent experiments; standard errors are shown. (B) Time-lapse videomicroscopy experiments
were performed with HEK/CD9P-1 cells transfected with CD9 or CD82. The mAbs directed against integrins a1 (FB12) or a2 (Gi9) were added to the
media (10 mg/ml). Three independent experiments were performed; standard errors are shown. (*) p,0.05, (**) p,0.01.
doi:10.1371/journal.pone.0011219.g006
Figure 7. Effects of tetraspanins on CD9P1-induced cell motility on fibronectin. HEK/CD9P-1 cells were transfected with tetraspanins CD9,
CD81, CD82 or CD9682. Then, cells were plated on fibronectin. Time-lapse videomicroscopy was performed at a rate of 1 frame per 15 min for 24h.
The results correspond to three independent experiments; standard errors are shown. (*) p,0.05, (**) p,0.01.
doi:10.1371/journal.pone.0011219.g007
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cytoplasmic domains of the CD9P-1 are required for inducing
effects on cell migration.
CD9 and CD81 regulate CD9P1-induced cell motility
The effect of tetraspanins on CD9P1-induced cell motility was
investigated because CD9P-1 is a major component of the
tetraspanin microdomains [15,21,24]. HEK/CD9P-1 cells were
transfected with plasmids encoding CD9, CD81, CD82 or CD151.
After 24h, similar expression levels of the transfected proteins were
observed at cell surface, using flow cytometry (Table 1). Cells were
plated on collagen I for 24h after transfection and time-lapse
videomicroscopy experiments were performed. An increase of
CD9 or CD81 expression significantly decreased HEK/CD9P-1
cell motility on collagen I whereas CD82 or CD151 expression
had no effect (Fig. 6A). The effect of tetraspanins on the migration
properties of HEK/CD9P-1 cells was also investigated using
Boyden chamber assay. An increase of CD9 expression decreased
the number of invaded cells when inserts were coated with
collagen I. As a control, the increased expression of CD82 had no
effect (data not shown).
The specific effect observed only with tetraspanins CD9 or
CD81 suggested a mechanism mediated through a direct
interaction with CD9P-1. Indeed, CD9P-1 specifically associates
with tetraspanins CD9 or CD81 to constitute robust primary
complexes [15,21,24]. To confirm the importance of these
primary complexes, the effect on cell motility of the chimera
protein CD9682 which does not associate with CD9P-1 [24] was
investigated. Interestingly, the chimera protein CD9682 had no
effect on HEK/CD9P-1 cell motility (Fig. 6A).
The effect of tetraspanin expression on a2b1-dependent cell
motility was investigated. Interestingly, HEK/CD9P-1 cells
transfected with CD9 were no longer sensitive to the a2-integrin
blocking antibody. As a control, CD82 expression had no effect on
the sensitivity of HEK/CD9P-1 cells to blocking antibodies
(Fig. 6B). It should be noted that CD9 was not observed to
associate with integrin a2b1 by immunoprecipitation experiments
after cell lysis using the mild detergent Brij58 (data not shown).
Additional experiments were performed on fibronectin. On this
matrix, CD9 and CD81 expression were observed to reverse the
effects induced by CD9P-1 expression on cell migration (Fig. 7).
In total, these results suggest that CD9 or CD81 can regulate
the functional effect of CD9P-1 on cell motility, which may be
related to a direct interaction between these tetraspanins and their
molecular partner.
CD9 or CD81 effects on cell motility are related to the
level of association with CD9P-1
The correlation between the level of association of CD9P-1 with
its tetraspanin partners and cell motility was investigated. The sub-
cellular distributions of CD9P-1 and CD9 were investigated by in
situ labelling of HEK-293 and HEK/CD9P-1 cells. As expected,
CD9 and CD9P-1 exhibited expression at the plasma membrane
and were co-localized in HEK-293 cells. CD9P-1 was also
observed to be highly expressed at the plasma membrane on
HEK/CD9P-1 cells. However, CD9 and CD9P-1 were co-
localized only at cell to cell contact in these cells on collagen I.
Indeed, a high signal corresponding to CD9P-1 was observed in
structures such as pseudopodia that did not contain any detectable
CD9 (Fig. 8). Although CD9P-1 associates specifically with CD9,
these observations suggest that some CD9P-1 can remain out of
tetraspanin microdomains in HEK/CD9P-1 cells. Furthermore,
CD9 was overexpressed in HEK/CD9P-1 cells after transfection
(HEK/CD9P-1/CD9). Under these conditions, the increased
expression of CD9 led to the restoration of a complete co-
localization of CD9P-1 and CD9 (Fig. 8). The amount of CD9P-1
associated with tetraspanins was further quantified by immuno-
precipitation experiments using tetraspanin mAbs following cell
lysis with the mild detergent Brij97 which has been demonstrated
to preserve tetraspanin complexes [15]. A good correlation was
observed between CD9 expression and the level of CD9P-1
association with tetraspanins (Fig. 9). These results suggest that the
ratio of expression levels between CD9P-1 and its tetraspanin
partners regulate cell motility.
Discussion
This is the first report addressing the function of the membrane
protein CD9P-1. We have demonstrated that CD9P-1 expression
induces dramatic changes in cell spreading and motility in HEK-
293 cells. Interestingly, the functional effects related to CD9P-1
expression appeared to be dependent of matrices such as collagen I
or fibronectin. Indeed, CD9P-1 plays a role as activator of cell
motility on collagen I, whereas it was observed to be an inhibitor
on fibronectin. CD9P-1 belongs to a new family of membrane
proteins with Ig domains that includes CD101, IgSF3 and EWI-2
[9]. Overexpression of EWI-2 in A431 epidermoid carcinoma cells
Figure 8. In situ labeling of CD9P-1 and CD9. HEK-293, HEK/CD9P-1 and HEK/CD9P-1 transfected (tr) with CD9 were plated on collagen I and
cultured in labtek chambers. After 24h, cells were fixed and in situ labeling was performed using CD9P-1 mAb (1F11, IgG1) and CD9 mAb TS9b (CD9,
IgG2b). Secondary antibodies, anti-IgG1 coupled to Alexa 568 and anti-IgG2 coupled to Alexa 488, were used for differential staining. Chromatin was
also stained using 300 nM DAPI. Images were acquired using optical microscopy with epifluorescence at the magnification 6306. Red: CD9P-1; green:
CD9; blue: nucleus.
doi:10.1371/journal.pone.0011219.g008
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functions on laminin-5 [43]. In the T leukaemia cell line Molt-4,
overexpression of EWI-2 markedly impaired spreading and
ruffling on VCAM-1 [44]. Furthermore, a mutant EWI-2
molecule with the cytoplasmic tail replaced by that of CD2
neither impaired neither cell spreading nor migration [43,44]. The
generation of CD9P-1 and HLA class I chimeric proteins
demonstrated that both the transmembrane and cytoplasmic
domains of CD9P-1 are involved in cell motility. Although the
CD9P-1 cytoplasmic domain is small, at only 26 aa, it appears to
be crucial in the activation of cell motility. This domain may
activate cell motility though its intracytoplasmic domain by
associating with the cytoskeleton. Indeed, CD9P-1 has been
demonstrated to associate with ERM (Ezrin, Radixin and Moesin)
Figure 9. Quantification of the amount of CD9P-1 associated with tetraspanins. The amount of CD9P-1 associated with tetraspanins or that
remaining outside the tetraspanin complexes was quantified in HEK-293 or HEK/CD9P-1 cells after transfection with CD9P-1 or/and CD9. Cells were
lysed using the mild detergent Brij97. CD9P-1 associated with tetraspanins was investigated by depletion of tetraspanins from the lysate. Three
rounds of subsequent immunoprecipitation were performed with mAbs directed against CD9 and CD81. After depletion of tetraspanin complexes,
the amount of CD9P-1 still remaining in the lysate and therefore not associated with tetraspanins was measured by three additional rounds of
immunoprecipitation using a mAb directed against CD9P-1 (1F11) antibody. All immunoprecipitates were separated by electrophoresis under
reducing conditions and proteins were stained using colloidal Coomassie blue. Gels were scanned using the Odyssey device (upper panel). Signals
obtained from CD9P-1 were measured and quantitated. When HEK-293 cells were transiently transfected with CD9P-1 (mfi=300 versus 50 from
endogenous), more than 70% of CD9P-1 was associated with tetraspanin partners CD9 (mfi=150) and CD81 (mfi=300). Furthermore, HEK-293 cells
were transfected with both plasmids encoding CD9P-1 and CD9. Under these conditions when CD9 expression level was higher (mfi=700), we
observed that 100% of CD9P-1 was associated with tetraspanins. In HEK/CD9P-1 cells that stably expressed CD9P-1 with a high level (mfi=1000), the
amount of CD9P-1 associated with tetraspanins was estimated to be 30%. When HEK/CD9P-1 cells were transfected with CD9 (mfi=700), a higher
amount, corresponding to 50% of CD9P-1, was associated with tetraspanins CD9 and CD81 (lower panel). A representative experiment is shown. IP:
immunoprecipitation; Tr: transfection.
doi:10.1371/journal.pone.0011219.g009
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consensus phosphorylation site (RXRXXS/T) [46] on serine 875
(RRRLMS). In a recent proteomic study, serine 875 has been
identified by mass spectrometry as being phosphorylated [47].
Thus, CD9P-1 may be involved in signaling upstream adhesion
molecules such as integrins.
CD9P-1 induced effects on cell motility are related to b1-
integrins as demonstrated by the use of blocking mAbs which
completely stopped cell migration. On collagen I, the increase of
cell motility may be related to integrin a2b1. With this regard,
CD9P-1 has been shown to associate with integrin a2b1.
However, the association between CD9P-1 and integrin a2b1
has only been observed using the mild detergent Brij58. This
suggests that activation of cell motility through integrin a2b1i s
most likely indirect and may necessitate other membrane proteins.
In addition, cross-linking experiments performed on living cells did
not show a direct interactions between those two membrane
proteins (data not shown). Therefore, it would be of great interest
to identify CD9P-1 associated proteins that may be involved in the
crosstalk between CD9P-1 and integrins as well as in signaling
upstream such molecules.
This study has suggested that tetraspanin microdomains can
play a role in the modulation of cell motility by the regulation of
CD9P-1 compartmentalization. Indeed, CD9P-1 exhibits a
dramatic effect on cell motility when located outside of tetraspanin
microdomains. The amount of CD9P-1 associated with tetra-
spanins has been precisely quantified by subsequent immunopre-
cipitations and measuring by infrared fluorescence on stained gels
[38]. In HEK-293 cells, tetraspanin microdomains contain the
total amount of CD9P-1. When CD9P-1 is overexpressed, a
fraction of CD9P-1 can localize to other membrane compartment,
as demonstrated by cell labeling and biochemical experiments.
These observations suggest a saturation of the tetraspanin
microdomains. Moreover, variation in the expression levels of
tetraspanins CD9 or CD81 induces a change in the fraction of
CD9P-1 contained in tetraspanin microdomains. It is important to
note that relocation of CD9P-1 into tetraspanin microdomains is
mediated by direct interaction with CD9 or CD81 because other
tetraspanins such as CD82 and CD151 which do not associate
directly with CD9P-1 had no effect (data not shown). Further-
more, CD9 or CD81 expression has been shown to reverse CD9P-
1 induced effects on cell motility with a concomitant association
with CD9P-1. These observations strengthen the impact of the
expression level of tetraspanins on membrane compartmentaliza-
tion of their partners and the functional relevance of such
microdomains. In pathological conditions such as cancer, variation
in the expression level of CD9 or CD81 may induce dramatic
effects on cell motility through a change in the membrane
compartmentalization of CD9P-1, thus favoring metastasis.
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